Biopharmaceutical products are drugs that are made from living cells. One protein type of high importance to biopharmaceuticals is monoclonal antibodies. Monoclonal antibodies allow for highly specific, targeted treatment of diseases and detection of molecules related to diseases. With major roles in detecting and/or treating diseases like human immunodeficiency virus (HIV), coronavirus disease 2019 (COVID-19), and some cancers, monoclonal antibodies are in demand. This demand has led to a need for efficient cell culture systems to produce high yields of protein with minimal waste. The most commonly used cell culture system for these high-value proteins is Chinese hamster ovary (CHO) cells. Understanding and modifying CHO cell culture condi...
In the past several decades, advances in our understanding of cells that comprise our bodies have be...
Chinese hamster ovary cells are the most commonly used expression system in the production of monocl...
Mammalian cell technology, whilst a mature platform for monoclonal antibody production, remains poor...
Biopharmaceutical products are drugs that are made from living cells. One protein type of high impor...
Lactate is one of the key waste metabolites of mammalian cell culture. High lactate levels are cause...
The development and application of fed-batch strategies have greatly contributed to the improvement ...
Chinese hamster ovary (CHO) cells are among the most commonly used mammalian cell lines for the prod...
The shift in lactate metabolism of industrial mammalian cell lines is a widely studied phenomenon th...
As the world population continues to grow and age, access to medical therapies, like therapeutic mon...
Chinese Hamster Ovary (CHO) cells are widely used in the industrial production of commercial therape...
Industrial bioprocesses place high demands on the intermediary metabolism of host cells to meet the ...
Industrial bioprocesses place extraordinary demands on the intermediary metabolism of host cells to ...
Lactate is a common metabolite and is central to many important processes. One of its more prominent...
Industrial fed-batch cultivation of mammalian cells is used for the production of therapeutic protei...
AbstractRecombinant yeast pyruvate carboxylase (PYC2) expression was previously shown to be an effec...
In the past several decades, advances in our understanding of cells that comprise our bodies have be...
Chinese hamster ovary cells are the most commonly used expression system in the production of monocl...
Mammalian cell technology, whilst a mature platform for monoclonal antibody production, remains poor...
Biopharmaceutical products are drugs that are made from living cells. One protein type of high impor...
Lactate is one of the key waste metabolites of mammalian cell culture. High lactate levels are cause...
The development and application of fed-batch strategies have greatly contributed to the improvement ...
Chinese hamster ovary (CHO) cells are among the most commonly used mammalian cell lines for the prod...
The shift in lactate metabolism of industrial mammalian cell lines is a widely studied phenomenon th...
As the world population continues to grow and age, access to medical therapies, like therapeutic mon...
Chinese Hamster Ovary (CHO) cells are widely used in the industrial production of commercial therape...
Industrial bioprocesses place high demands on the intermediary metabolism of host cells to meet the ...
Industrial bioprocesses place extraordinary demands on the intermediary metabolism of host cells to ...
Lactate is a common metabolite and is central to many important processes. One of its more prominent...
Industrial fed-batch cultivation of mammalian cells is used for the production of therapeutic protei...
AbstractRecombinant yeast pyruvate carboxylase (PYC2) expression was previously shown to be an effec...
In the past several decades, advances in our understanding of cells that comprise our bodies have be...
Chinese hamster ovary cells are the most commonly used expression system in the production of monocl...
Mammalian cell technology, whilst a mature platform for monoclonal antibody production, remains poor...